Formulary

September 15, 2022

Insulin, albuterol, epinephrine, glucagon and naloxone are on the list.

September 09, 2022

Some companies are using the interchangeability designation as a marketing ploy.

August 23, 2022

Most of the respondents to the survey agreed that negotiations by pharmacy benefit managers (PBMs) lowers net drug prices. About half favored imposing transparency rules on PBMs.

August 22, 2022

The respondents were almost evenly split on whether it was a mistake for the FDA to approve Aduhelm, but a large majority agreed that CMS made the right decision to restrict Medicare coverage to those enrolled in clinical trials.

August 01, 2022

Those living with diabetes who don't have insurance will pay $35 for a 30-day supply of Sanofi U.S. insulins.

July 22, 2022

The president of CVS Caremark discusses specialty pharmacy, competition for the specialty patient and Humira biosimilars hitting the market next year.

July 21, 2022

The president of CVS Caremark discusses competition in the PBM industry, new entrants into the business, transparency and the reasons for establishing a group purchasing organization.

July 12, 2022

The Big Three all set up group purchasing organizations recently, but some industry observers question the timing of the move and who will benefit.

July 06, 2022

The case concerns the controversial direct and indirect remuneration (DIR) fees that pharmacy benefit managers (PBMs) collect from pharmacies. Meanwhile, a separate whistleblower lawsuit has been filed against CVS Caremark, its parent company and SilverScripts, its Part D plan, accusing them of blocking customers from getting cheaper generic drugs.

June 24, 2022

Harvard researchers calculated that buying 77 generic drugs at prices being charged by Mark Cuban’s online pharmacy prices would have lowered Medicare spending on those drugs from $9.6 billion to $6 billion.